Protein biomarkers for the diagnosis and prognosis of Amyotrophic Lateral Sclerosis
Neuroscience Research · 2023-12 · 197 · 31-41
DOI: 10.1016/j.neures.2023.09.002 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Neuroscience Research, 2023-12. Verfasst von Luisa Donini und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cellular, Computational and Integrative Biology - CIBIO, University of Trento, Italy. Electronic address: luisa.donini@unitn.it. Hauptthemen laut MEDLINE: Amyotrophic Lateral Sclerosis. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 111 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Fondazione Italiana di Ricerca per la Sclerosi Laterale Amiotrofica.
Abstract (Originalsprache)
Amyotrophic Lateral Sclerosis (ALS) is the most common motor neuron disease, still incurable. The disease is highly heterogenous both genetically and phenotypically. Therefore, developing efficacious treatments is challenging in many aspects because it is difficult to predict the rate of disease progression and stratify the patients to minimize statistical variability in clinical studies. Moreover, there is a lack of sensitive measures of therapeutic effect to assess whether a pharmacological intervention ameliorates the disease. There is also urgency of markers that reflect a molecular mechanism dysregulated by ALS pathology and can be rescued when a treatment relieves the condition. Here, we summarize and discuss biomarkers tested in multicentered studies and across different laboratories like neurofilaments, the most used marker in ALS clinical studies, neuroinflammatory-related proteins, p75ECD, p-Tau/t-Tau, and UCHL1. We also explore the applicability of muscle proteins and extracellular vesicles as potential biomarkers.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cellular, Computational and Integrative Biology - CIBIO, University of Trento, Italy. Electronic address: luisa.donini@unitn.it.
- Clinical Center NeMO, APSS Ospedale Riabilitativo Villa Rosa, Pergine 38057, TN, Italy. Electronic address: raffaella.tanel@apss.tn.it.
- Clinical Center NeMO, APSS Ospedale Riabilitativo Villa Rosa, Pergine 38057, TN, Italy.
- Department of Cellular, Computational and Integrative Biology - CIBIO, University of Trento, Italy. Electronic address: manuela.basso@unitn.it.
Förderung
- Fondazione Italiana di Ricerca per la Sclerosi Laterale Amiotrofica
Zitieren
APA
Donini, L., Tanel, R., Zuccarino, R., & Basso, M. (2023). Protein biomarkers for the diagnosis and prognosis of Amyotrophic Lateral Sclerosis. Neuroscience Research, 197, 31-41. https://doi.org/10.1016/j.neures.2023.09.002
Vancouver
Donini L, Tanel R, Zuccarino R, Basso M. Protein biomarkers for the diagnosis and prognosis of Amyotrophic Lateral Sclerosis. Neuroscience Research. 2023;197:31-41. doi:10.1016/j.neures.2023.09.002
BibTeX
@article{Donini2023,
author = {Donini, Luisa and Tanel, Raffaella and Zuccarino, Riccardo and Basso, Manuela},
title = {Protein biomarkers for the diagnosis and prognosis of Amyotrophic Lateral Sclerosis},
journal = {Neuroscience Research},
year = {2023},
volume = {197},
pages = {31--41},
doi = {10.1016/j.neures.2023.09.002}
}
EUVIMED